<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="423">
  <stage>Registered</stage>
  <submitdate>6/09/2005</submitdate>
  <approvaldate>22/09/2005</approvaldate>
  <actrnumber>ACTRN12605000457640</actrnumber>
  <trial_identification>
    <studytitle>The effects of portable, exertional oxygen in chronic obstructive pulmonary disease.</studytitle>
    <scientifictitle>A randomised, double-blinded, controlled trial to evaluate the effects of portable, exertional oxygen  upon dyspnoea, quality of life and exercise tolerance in chronic obstructive pulmonary disease</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Chronic obstructive pulmonary disease</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Chronic obstructive pulmonary disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects who have COPD but are not severely hypoxaemic at rest are randomised to receive either portable, compressed oxygen or portable compressed air to use during exertional activities for a period of 12 weeks.</interventions>
    <comparator />
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Dyspnoea</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Exercise tolerance</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Activity levels</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Depression symptoms</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Service utilisation</outcome>
      <timepoint>At baseline, 4 weeks and 12 weeks.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosis of chronic obstructive pulmonary disease, non-smoker, activity limited by breathlessness, clinically stable for previous 4 weeks, does not qualify for long term oxygen therapy (PaO2 &gt; 55 mmHg), not currently receiving home oxygen therapy.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Significant locomotor disability, other severe disabling medical condition, currently attending a Pulmonary Rehabilitation Program.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>A computer-generated list of random numbers is used to allocate participants to the control or intervention group.  Assignment to groups is undertaken by the supplier of the portable cylinders, and is thus concealed from the investigators.</concealment>
    <sequence>Allocation to the intervention or control group is undertaken on an odd or even number basis from a list of random numbers, which was computer-generated, using Microsoft Excel software.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>8/05/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>160</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Northern Clinical Research Centre</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>The Northern Clinical Research Centre</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>The Austin Hospital Medical Research Foundation</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Air Liquide Pty Limited</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Boehringer Ingelheim Pty Limited</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Department of Respiratory Medicine, Austin Health</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This project aims to investigate the effects of portable oxygen, used during activity, by people who have chronic obstructive pulmonary disease.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Northern Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The Austin Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor Christine McDonald</name>
      <address>Department of Respiratory Medicine
The Austin Hospital
Studley Road
Heidelberg VIC 3084</address>
      <phone>+61 3 94965739</phone>
      <fax>+61 3 94963723</fax>
      <email>christine.mcdonald@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rosemary Moore</name>
      <address>Research Fellow
The Northern Clinical Research Centre
The Northern Hospital
185 Cooper Street
Epping VIC 3076</address>
      <phone>+61 3 84058480</phone>
      <fax>+61 3 84058683</fax>
      <email>rosemary.moore@nh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>